Authority: Supreme Court of India

Order Date: 18 July 2026

Case Overview

  • Parties: CIPLA LIMITED (Petitioner) vs NATIONAL PHARMACEUTICAL PRICING AUTHORITY & ORS. (Respondents).
  • Petition: Special Leave to Appeal (C) No. 23021/2026, arising from the impugned final judgment and order dated 24‑04‑2026 in WP No. 2069/2022 passed by the High Court of Judicature at Bombay.
  • Nature of Proceeding: The petitioner seeks permission to file additional documents, facts, and annexures (IA No. 193017/2026) and to maintain interim protection previously granted by the High Court.
  • Background: The High Court, in paragraph 31 of its judgment, had granted interim protection to Cipla. Cipla filed a petition before the Supreme Court requesting further relief and the ability to supplement its pleadings.
  • Hearing: The matter was called for hearing on 17‑07‑2026 before a bench comprising Hon'ble Mr. Justice Pamidighantam, Hon'ble Mr. Justice Sri Narasimha, and Hon'ble Mr. Justice Alok Aradhe.

Court Observations & Directions

1. Notice Issuance: The Court ordered that a notice be issued, which shall be returnable on or before 14‑08‑2026.

2. Permission for Additional Documents: The Court permitted the filing of additional documents, facts, and annexures (referred to as “Dasti”) by the petitioner.

3. Extension of Interim Protection: The interim protection granted by the High Court in paragraph 31 of the impugned judgment is extended until the next date of hearing.

Final Outcome

  • The Supreme Court granted Cipla permission to file supplementary documents and extended the High Court’s interim protection, with a notice to be returned by 14 August 2026.

Topics: Pharma Pricing, Court Proceedings